In this study, we investigated whether circulating transcript and plasma protein levels of HN and MOTS-c could serve as biomarkers for Alzheimer’s disease (AD) risk and progression across the cognitive impairment spectrum. The gene discussed is MT-RNR1; the disease is early-onset autosomal dominant Alzheimer disease.